Ftse Mib
34.888,79
0,09%
DAX
20.405,92
-0,11%
S&P 500
6.051,09
0,00%
NASDAQ
19.926,72
0,12%
Bitcoin
102.194,01
0,72%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Innate Pharma SA (IPHA) Innate Pharma SA (IPHA) Notizie

Innate Pharma SA

IPHA
3,10
1,55 (100,00%)
14 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/12/202412:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/12/202407:00BWInnate Pharma Presents Lacutamab Improved Health-related..
06/12/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/12/202407:00BWInnate Pharma and the Institute for Follicular Lymphoma..
03/12/202412:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/12/202407:00BWInnate Pharma Highlights Abstracts Selected for the ASH..
20/11/202412:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202407:00BWInnate Pharma publie son calendrier financier pour 2025
19/11/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/11/202407:00BWInnate Pharma Announces Publication in Science Immunology..
13/11/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202407:00BWInnate Pharma Reports Third Quarter 2024 Business Update and..
08/11/202412:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/11/202407:00BWInnate Pharma annonce les présentations de données de son..
07/11/202407:00BWInnate Pharma organise une conférence téléphonique pour ses..
29/10/202407:00BWInnate Pharma annonce sa participation à de prochaines..
14/10/202407:00BWJonathan Dickinson est nommé Président du Directoire..
30/9/202407:00BWInnate Pharma to Host KOL Scientific Symposium on..
23/9/202412:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/9/202407:00BWInnate Pharma Announces FDA Clearance of the IND for..
12/9/202412:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202412:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/9/202412:04IHMARKETNEWSU.S. Index Futures Climb Ahead of Key Economic Data..
12/9/202407:00BWInnate Pharma Reports First Half 2024 Business Update and..
11/9/202422:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/9/202407:00BWInnate Pharma SA: Présentation de données de monalizumab..
05/9/202407:00BWInnate Pharma Announces Conference Call and Webcast for..
04/9/202407:00BWInnate Pharma Announces Its Participation in the H.C...
01/8/202407:00BWINNATE PHARMA ANNONCE SA PARTICIPATION A UNE PROCHAINE..
25/7/202407:00BWNumber of Shares and Voting Rights of Innate Pharma as of..
18/6/202407:00BWNumber of Shares and Voting Rights of Innate Pharma as of..
17/6/202407:00BWInnate Pharma partage de nouveaux résultats concernant..
04/6/202412:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
04/6/202407:00BWInnate Pharma présente les résultats positifs de l’étude de..
28/5/202412:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/5/202407:00BWInnate Pharma Announces Its Participation in Upcoming..
24/5/202412:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/5/202407:00BWInnate Pharma partage les abstracts sélectionnés pour le..
23/5/202422:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/5/202422:00BWRésultats de l’Assemblée Générale mixte du 23 mai 2024
21/5/202407:00BWInnate Pharma: Clarification concernant le statut de..
15/5/202412:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/5/202407:00BWInnate Pharma Highlights Abstracts Selected for EHA 2024..
14/5/202407:00BWInnate Pharma fait le point sur ses activités et publie ses..
07/5/202407:00BWInnate Pharma organise une conférence téléphonique pour..
15/4/202407:00BWInnate Pharma annonce la progression de l’essai clinique..
10/4/202407:00BWInnate Pharma présente des données d’efficacité précliniques..
09/4/202407:00BWInnate Pharma Announces Its Participation in Upcoming..
05/4/202409:34BWInnate Pharma publie son Document D’enregistrement Universel..
21/3/202407:00BWInnate Pharma présente ses résultats financiers et l'avancée..
Apertura: 1,50 Min: 1,47 Max: 3,5107
Chiusura: 1,55

La tua Cronologia

NASDAQ
IPHA
Innate Pharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network